Any feedback?
Please rate this page
(enzyme.php)
(0/150)

BRENDA support

Disease on EC 1.8.3.4 - methanethiol oxidase

Please use the Disease Search for a specific query.
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
DISEASE
TITLE OF PUBLICATION
LINK TO PUBMED
Acute Coronary Syndrome
Circulating levels of selenium-binding protein 1 (SELENBP1) are associated with risk for major adverse cardiac events and death.
Acute Kidney Injury
Identification of a sensitive urinary biomarker, selenium-binding protein 1, for early detection of acute kidney injury.
Adenocarcinoma
Decreased selenium-binding protein 1 in esophageal adenocarcinoma results from posttranscriptional and epigenetic regulation and affects chemosensitivity.
Adenocarcinoma of Lung
Potential relationship between the selenoproteome and cancer.
Reduced selenium-binding protein 1 expression is associated with poor outcome in lung adenocarcinomas.
Tumor Suppressor Activity of Selenbp1, a Direct Nkx2-1 Target, in Lung Adenocarcinoma.
Adenoma
Suppression of human selenium-binding protein 1 is a late event in colorectal carcinogenesis and is associated with poor survival.
Barrett Esophagus
Decreased selenium-binding protein 1 in esophageal adenocarcinoma results from posttranscriptional and epigenetic regulation and affects chemosensitivity.
Bradycardia
Selenium-Binding Protein 1 Indicates Myocardial Stress and Risk for Adverse Outcome in Cardiac Surgery.
Brain Ischemia
Selenium-Binding Protein 1 Indicates Myocardial Stress and Risk for Adverse Outcome in Cardiac Surgery.
Breast Neoplasms
Reduced selenium-binding protein 1 in breast cancer correlates with poor survival and resistance to the anti-proliferative effects of selenium.
Carcinogenesis
Progressive loss of selenium-binding protein 1 expression correlates with increasing epithelial proliferation and papillary complexity in ovarian serous borderline tumor and low-grade serous carcinoma.
Suppression of human selenium-binding protein 1 is a late event in colorectal carcinogenesis and is associated with poor survival.
The Function and Significance of SELENBP1 Downregulation in Human Bronchial Epithelial Carcinogenic Process.
Carcinoma
Altered expression of selenium-binding protein 1 in gastric carcinoma and precursor lesions.
Decreased selenium-binding protein 1 mRNA expression is associated with poor prognosis in renal cell carcinoma.
Downregulation of SELENBP1 enhances oral squamous cell carcinoma chemoresistance through KEAP1-NRF2 signaling.
Downregulation of selenium-binding protein 1 is associated with poor prognosis in lung squamous cell carcinoma.
Progressive loss of selenium-binding protein 1 expression correlates with increasing epithelial proliferation and papillary complexity in ovarian serous borderline tumor and low-grade serous carcinoma.
Reduced selenium-binding protein 1 is associated with poor survival rate in gastric carcinoma.
Selenium-binding protein 1 in head and neck cancer is low-expression and associates with the prognosis of nasopharyngeal carcinoma.
Selenium-binding protein 1 is down-regulated in malignant melanoma.
Selenium-binding protein 1: Its physiological function, dependence on aryl hydrocarbon receptors, and role in wasting syndrome by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Suppression of human selenium-binding protein 1 is a late event in colorectal carcinogenesis and is associated with poor survival.
Carcinoma, Hepatocellular
Decreased selenium-binding protein 1 enhances glutathione peroxidase 1 activity and downregulates HIF-1? to promote hepatocellular carcinoma invasiveness.
Evaluation of selenite effects on selenoproteins and cytokinome in human hepatoma cell lines.
Hepatitis B Virus-X Downregulates Expression of Selenium Binding Protein 1.
Invasive potential of hepatocellular carcinoma is enhanced by loss of selenium-binding protein 1 and subsequent upregulation of CXCR4.
Potential relationship between the selenoproteome and cancer.
Carcinoma, Renal Cell
Decreased selenium-binding protein 1 mRNA expression is associated with poor prognosis in renal cell carcinoma.
Carcinoma, Squamous Cell
Downregulation of selenium-binding protein 1 is associated with poor prognosis in lung squamous cell carcinoma.
Selenium-binding protein 1 in head and neck cancer is low-expression and associates with the prognosis of nasopharyngeal carcinoma.
Cholangiocarcinoma
Reduced selenium-binding protein 1 correlates with a poor prognosis in intrahepatic cholangiocarcinoma and promotes the cell epithelial-mesenchymal transition.
Colitis
DNA Methylation of miR-122 Aggravates Oxidative Stress in Colitis Targeting SELENBP1 Partially by p65NF-?B Signaling.
Colonic Neoplasms
Selenium-binding protein 1 is associated with the degree of colorectal cancer differentiation and is regulated by histone modification.
Colorectal Neoplasms
Expression of selenium-binding protein 1 characterizes intestinal cell maturation and predicts survival for patients with colorectal cancer.
Selenium-binding protein 1 is associated with the degree of colorectal cancer differentiation and is regulated by histone modification.
Suppression of human selenium-binding protein 1 is a late event in colorectal carcinogenesis and is associated with poor survival.
Transcriptional regulation and biological functions of selenium-binding protein 1 in colorectal cancer in vitro and in nude mouse xenografts.
Congenital Abnormalities
Protective Effects of Sal B on Oxidative Stress-Induced Aging by Regulating the Keap1/Nrf2 Signaling Pathway in Zebrafish.
Cysts
Progressive loss of selenium-binding protein 1 expression correlates with increasing epithelial proliferation and papillary complexity in ovarian serous borderline tumor and low-grade serous carcinoma.
Dengue
Genetic Profiling and Comorbidities of Zika Infection.
Fatty Liver
Identification of a differentially-expressed gene in fatty liver of overfeeding geese.
Selenium-binding protein 1 (SELENBP1) is a marker of mature adipocytes.
Glaucoma
Integrated microarray analysis provided novel insights to the pathogenesis of glaucoma.
Head and Neck Neoplasms
Selenium-binding protein 1 in head and neck cancer is low-expression and associates with the prognosis of nasopharyngeal carcinoma.
Heart Arrest
Selenium-Binding Protein 1 Indicates Myocardial Stress and Risk for Adverse Outcome in Cardiac Surgery.
Hepatitis B
Hepatitis B Virus-X Downregulates Expression of Selenium Binding Protein 1.
Hypopharyngeal Neoplasms
Selenium-binding protein 1 in head and neck cancer is low-expression and associates with the prognosis of nasopharyngeal carcinoma.
Infections
Genetic Profiling and Comorbidities of Zika Infection.
Hepatitis B Virus-X Downregulates Expression of Selenium Binding Protein 1.
Infertility
Selenium-Binding Protein 1 (SBP1) autoantibodies in ovarian disorders and ovarian cancer.
Laryngeal Neoplasms
Selenium-binding protein 1 in head and neck cancer is low-expression and associates with the prognosis of nasopharyngeal carcinoma.
Leiomyoma
The expression of selenium-binding protein 1 is decreased in uterine leiomyoma.
Liver Cirrhosis
Quantitative chemical proteomics for investigating the biomarkers of dioscin against liver fibrosis caused by CCl4 in rats.
Liver Diseases
Selenium-binding protein 1 (SELENBP1) is a marker of mature adipocytes.
Lung Injury
[Relationship between the expression of heat shock protein 25 and selenium binding protein 1 with ischemia/reperfusion lung injury in vivo: experiment with rats]
Lung Neoplasms
Proteomic analysis distinguishes basaloid carcinoma as a distinct subtype of nonsmall cell lung carcinoma.
Tumor Suppressor Activity of Selenbp1, a Direct Nkx2-1 Target, in Lung Adenocarcinoma.
Lymphatic Metastasis
Selenium-binding protein 1 is associated with the degree of colorectal cancer differentiation and is regulated by histone modification.
Suppression of selenium-binding protein 1 in gastric cancer is associated with poor survival.
Melanoma
Selenium-binding protein 1 is down-regulated in malignant melanoma.
Mouth Neoplasms
Selenium-binding protein 1 in head and neck cancer is low-expression and associates with the prognosis of nasopharyngeal carcinoma.
Myocardial Infarction
Selenium-Binding Protein 1 (SELENBP1) as Biomarker for Adverse Clinical Outcome After Traumatic Spinal Cord Injury.
Selenium-Binding Protein 1 Indicates Myocardial Stress and Risk for Adverse Outcome in Cardiac Surgery.
Myocardial Ischemia
Selenium-Binding Protein 1 Indicates Myocardial Stress and Risk for Adverse Outcome in Cardiac Surgery.
Nasopharyngeal Carcinoma
Selenium-binding protein 1 in head and neck cancer is low-expression and associates with the prognosis of nasopharyngeal carcinoma.
Neoplasm Metastasis
Selenium-binding protein 1 is associated with the degree of colorectal cancer differentiation and is regulated by histone modification.
Suppression of selenium-binding protein 1 in gastric cancer is associated with poor survival.
Tumor Suppressor Activity of Selenbp1, a Direct Nkx2-1 Target, in Lung Adenocarcinoma.
Neoplasms
Altered expression of selenium-binding protein 1 in gastric carcinoma and precursor lesions.
Decreased selenium-binding protein 1 mRNA expression is associated with poor prognosis in renal cell carcinoma.
Diverse proteomic alterations in gastric adenocarcinoma.
Downregulation of SELENBP1 enhances oral squamous cell carcinoma chemoresistance through KEAP1-NRF2 signaling.
Evaluation of autoantibody signatures in meningioma patients using human proteome arrays.
Evidence that selenium binding protein 1 is a tumor suppressor in prostate cancer.
Hepatitis B Virus-X Downregulates Expression of Selenium Binding Protein 1.
Inverse association between glutathione peroxidase activity and both selenium-binding protein 1 levels and gleason score in human prostate tissue.
Molecular cross-talk between members of distinct families of selenium containing proteins.
Mutations in SELENBP1, encoding a novel human methanethiol oxidase, cause extraoral halitosis.
Progressive loss of selenium-binding protein 1 expression correlates with increasing epithelial proliferation and papillary complexity in ovarian serous borderline tumor and low-grade serous carcinoma.
Quantitative Proteomics Analysis Integrated with Microarray Data Reveals That Extracellular Matrix Proteins, Catenins, and P53 Binding Protein 1 Are Important for Chemotherapy Response in Ovarian Cancers.
Reduced selenium-binding protein 1 correlates with a poor prognosis in intrahepatic cholangiocarcinoma and promotes the cell epithelial-mesenchymal transition.
Reduced selenium-binding protein 1 expression is associated with poor outcome in lung adenocarcinomas.
Reduced selenium-binding protein 1 is associated with poor survival rate in gastric carcinoma.
Reduction of selenium-binding protein 1 sensitizes cancer cells to selenite via elevating extracellular glutathione: A novel mechanism of cancer-specific cytotoxicity of selenite.
Selenium binding protein 1 in ovarian cancer.
Selenium-binding protein 1 (SELENBP1) is a marker of mature adipocytes.
Selenium-binding protein 1 as a tumor suppressor and a prognostic indicator of clinical outcome.
Selenium-Binding Protein 1 expression in ovaries and ovarian tumors in the laying hen, a spontaneous model of human ovarian cancer.
Selenium-binding protein 1 in head and neck cancer is low-expression and associates with the prognosis of nasopharyngeal carcinoma.
Selenium-binding protein 1 is associated with the degree of colorectal cancer differentiation and is regulated by histone modification.
Selenium-binding protein 1 is down-regulated in malignant melanoma.
Selenium-binding protein 1 transcriptionally activates p21 expression via p53-independent mechanism and its frequent reduction associates with poor prognosis in bladder cancer.
Selenium-binding protein 1: Its physiological function, dependence on aryl hydrocarbon receptors, and role in wasting syndrome by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Suppression of selenium-binding protein 1 in gastric cancer is associated with poor survival.
The expression of selenium-binding protein 1 is decreased in uterine leiomyoma.
The Function and Significance of SELENBP1 Downregulation in Human Bronchial Epithelial Carcinogenic Process.
Transcriptional regulation and biological functions of selenium-binding protein 1 in colorectal cancer in vitro and in nude mouse xenografts.
Tumor Suppressor Activity of Selenbp1, a Direct Nkx2-1 Target, in Lung Adenocarcinoma.
Neoplasms, Squamous Cell
The Function and Significance of SELENBP1 Downregulation in Human Bronchial Epithelial Carcinogenic Process.
Neoplastic Processes
Inherited cancer predisposition sensitizes colonic mucosa to address Western diet effects and putative cancer-predisposing changes on mouse proteome.
Non-alcoholic Fatty Liver Disease
Selenium-binding protein 1 (SELENBP1) is a marker of mature adipocytes.
Ovarian Neoplasms
Selenium binding protein 1 in ovarian cancer.
Selenium-Binding Protein 1 (SBP1) autoantibodies in ovarian disorders and ovarian cancer.
Selenium-Binding Protein 1 expression in ovaries and ovarian tumors in the laying hen, a spontaneous model of human ovarian cancer.
Polycystic Ovary Syndrome
A nontargeted proteomic study of the influence of androgen excess on human visceral and subcutaneous adipose tissue proteomes.
Primary Ovarian Insufficiency
Selenium-Binding Protein 1 (SBP1) autoantibodies in ovarian disorders and ovarian cancer.
Prostatic Neoplasms
Evidence that selenium binding protein 1 is a tumor suppressor in prostate cancer.
Selenium-binding protein 1 alters energy metabolism in prostate cancer cells.
Selenoprotein and antioxidant genes and the risk of high-grade prostate cancer and prostate cancer recurrence.
protein kinase c deficiency
Loss of PKC-delta alters cardiac metabolism.
Spinal Cord Injuries
Selenium-Binding Protein 1 (SELENBP1) as Biomarker for Adverse Clinical Outcome After Traumatic Spinal Cord Injury.
Spinal Curvatures
Protective Effects of Sal B on Oxidative Stress-Induced Aging by Regulating the Keap1/Nrf2 Signaling Pathway in Zebrafish.
Squamous Cell Carcinoma of Head and Neck
Downregulation of SELENBP1 enhances oral squamous cell carcinoma chemoresistance through KEAP1-NRF2 signaling.
Selenium-binding protein 1 in head and neck cancer is low-expression and associates with the prognosis of nasopharyngeal carcinoma.
Stomach Neoplasms
Suppression of selenium-binding protein 1 in gastric cancer is associated with poor survival.
Tonsillar Neoplasms
Selenium-binding protein 1 in head and neck cancer is low-expression and associates with the prognosis of nasopharyngeal carcinoma.
Urinary Bladder Neoplasms
Selenium-binding protein 1 transcriptionally activates p21 expression via p53-independent mechanism and its frequent reduction associates with poor prognosis in bladder cancer.
Wasting Syndrome
Selenium-binding protein 1: Its physiological function, dependence on aryl hydrocarbon receptors, and role in wasting syndrome by 2,3,7,8-tetrachlorodibenzo-p-dioxin.